1 / 7

Bramlage P, et al. J Clin Hyper. doi: 10.1111/j.1751-7176.2010.00322.x

A Global Perspective on Blood Pressure Treatment and Control in a Referred Cohort of Hypertensive Patients. Problematic: Scarce data on BP treatment, BP control and drug utilization on global scale Goal:

ginger-thornton
Download Presentation

Bramlage P, et al. J Clin Hyper. doi: 10.1111/j.1751-7176.2010.00322.x

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A Global Perspective on Blood Pressure Treatment and Control in a Referred Cohort of Hypertensive Patients Problematic: Scarce data on BP treatment, BP control and drug utilization on global scale Goal: Resolve the lack of information to gain further insight into national and regional BP control and antihypertensive pharmacotherapy prescribed in practice by analyzing the data of i-SEARCH (International survey) Bramlage P, et al. J Clin Hyper. doi: 10.1111/j.1751-7176.2010.00322.x

  2. i-SEARCH method 26 countries across the world (n=18 652)

  3. i-SEARCH method Baseline characteristics: Treated patients: n= 18 652 Age (years): 63.0 ± 11.4 Sex (male): 52.2% Type 2 diabetes: 24.3% SBP (mm Hg): 148.2 ± 19.8 DBP (mm Hg): 86.7 ± 11.6

  4. The majority of hypertensive patients are uncontrolled Uncontrolled Patients BP control (%)

  5. 1 hypertensive patient out of 3 is treated by 3 drugs

  6. Similar use of drug regardless ofthe region of the world

  7. Conclusion • BP reading were on average too high and not tailored toward an increased risk • Potential for an improvement of BP control in daily practice • This would result in considerable reductions of morbidity

More Related